A Win For Viking Therapeutics, Inc.

Tue, Feb 27, 2024 at 07:12 PM

Viking Therapeutics, Inc. (VKTX:NASDAQ) soared at $85.05, a gain of 121%. On Tue, Feb 27, 2024, VKTX:NASDAQ hit a New 2-Week High of $85.05. The stock got featured on our News Catalysts scanner on Tue, Feb 27, 2024 at 05:51 PM in the 'PUBLIC OFFERING' category. From Tue, Feb 13, 2024, the stock recorded 66.67% Up Days and 70.00% Green Days

About Viking Therapeutics, Inc. (VKTX:NASDAQ)

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

Top 10 Gainers:

Janux Therapeutics Inc. (JANX:NASDAQ), 229.47%
Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
Viking Therapeutics, Inc. (VKTX:NASDAQ), 121.02%
CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 81.94%
Presto Automation Inc Com (PRST:NASDAQ), 74.05%
SRAX, Inc. (SRAX:NASDAQ), 66.67%
Sarcos Technology and Robotics Corporation (STRC:NASDAQ), 62.09%
Vicarious Surgical Inc. Class A (RBOT:NYSE), 57.11%
Biora Therapeutics Inc. (BIOR:NASDAQ), 46.67%
JetAI Inc Com (JTAI:NASDAQ), 44.15%